BCL2 and glioma: These results are consistent with our previous study showing that overexpression of CEBPD upregulated antiapoptotic B-cell lymphoma 2 (BCL2) and the proliferation regulator c-MYC and downregulated proapoptotic BCL2-associated X protein (BAX) expression in glioma cells [37].